Transanal total mesorectal excision for adult patients with rectal cancer a review of clinical effectiveness and cost-effectiveness
Colorectal cancer is the third most commonly diagnosed cancer in Canada. In 2019 in Canada, colorectal cancer made up 13% of cancer cases in males, and 11% of cancer cases in females. The purpose of the report is to review and critically appraise the evidence pertaining to the clinical effectiveness...
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2020, April 24, 2020
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Colorectal cancer is the third most commonly diagnosed cancer in Canada. In 2019 in Canada, colorectal cancer made up 13% of cancer cases in males, and 11% of cancer cases in females. The purpose of the report is to review and critically appraise the evidence pertaining to the clinical effectiveness and the cost-effectiveness of the TaTME for adult patients with middle to distal rectal cancer compared to open and laparoscopic TME. This information may be use used to inform decision making relating to clinical practice for the use of TaTME. |
|---|---|
| Physical Description: | 1 PDF file (39 pages) illustration |